Day One Bio News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Day One Bio. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Day One Bio Today - Breaking & Trending Today

Addressing Unmet Need: Could Children With Low-Grade Gliomas Have a New Treatment in Tovorafenib?

Published: May 6, 2023

For Brain Cancer Awareness Month, AJMC shares an interview with Day One Biopharmaceuticals CEO Jeremy Bender, PhD, MBA. Bender discussed the company's lead agent, tovorafenib, which has shown promise in treatment of pediatric low-grade glioma.

Source: ajmc.com

Related Topics:

United StatesJeremy BenderSociety For NeuroAmerican Society Of Clinical OncologyAmerican Society Of Pediatric Oncology Hematology ConferenceOncology Research ConferenceDay One BiopharmaceuticalsDay OneResponse AssessmentRare Pediatric DiseaseAmerican JournalManaged CareJude ChildrenBrain Cancer Awareness MonthDay One BioAmerican SocietyHematology ConferenceClinical Oncology AnnualNew Drug ApplicationAccessed MayClinical OncologyPublished AprilGonazles Del PinoBrain TumorsLow Grade Gliomas